Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS
Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1748-1749
DOI: 10.1200/jco-26-00311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Melissa L Johnson. Beteiligte Einrichtung: Melissa L. Johnson, MD, Sarah Cannon Research Institute, Nashville, TN. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Melissa L. Johnson, MD, Sarah Cannon Research Institute, Nashville, TN.
ORCID-Profile: Melissa L Johnson
Zitieren
APA
Johnson, M. L. (2026). Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS. Journal of Clinical Oncology, 44(18), 1748-1749. https://doi.org/10.1200/jco-26-00311
Vancouver
Johnson ML. Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS. Journal of Clinical Oncology. 2026;44(18):1748-1749. doi:10.1200/jco-26-00311
BibTeX
@article{Johnson2026,
author = {Johnson, Melissa L},
title = {Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {18},
pages = {1748--1749},
doi = {10.1200/jco-26-00311}
}
EUVIMED